Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor

Marzia Occhino, Fabio Ghiotto, Simonetta Soro, Mimosa Mortarino, Stefania Bosi, Massimo Maffei, Silvia Bruno, Marco Nardini, Mariangela Figini, Anna Tramontano, Ermanno Ciccone

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

UL18 is a glycoprotein encoded by the human cytomegalovirus genome and is thought to play a pivotal role during human cytomegalovirus infection, although its exact function is still a matter of debate. UL18 shares structural similarity with MHC class I and binds the receptor CD85j on immune cells. Besides UL18, CD85j binds MHC class I molecules. The binding properties of CD85j to MHC class I molecules have been thoroughly studied. Conversely, very little information is available on the CD85j/UL18 complex, namely that UL18 binds CD85j through its α3 domain with an affinity that is ∼1000-fold higher than the MHC class I affinity for CD85j. Deeper knowledge of features of the UL18/CD85j complex would help to disclose the function of UL18 when it binds to CD85j. In this study we first demonstrated that the UL18α3 domain is not sufficient per se for binding and that β2-microglobulin is necessary for UL18-CD85j interaction. We then dissected structural determinants of binding UL18 to CD85j. To this end, we constructed a three-dimensional model of the complex. The model was used to design mutants in selected regions of the putative interaction interface, the effects of which were measured on binding. Six regions in both the α2 and α3 domains and specific amino acids within them were identified that are potentially involved in the UL18-CD85j interaction. The higher affinity of UL18 to CD85j, compared with MHC class I, seems to be due not to additional interaction regions but to an overall better fit of the two molecules.

Original languageEnglish
Pages (from-to)957-968
Number of pages12
JournalJournal of Immunology
Volume180
Issue number2
Publication statusPublished - Jan 15 2008

Fingerprint

Cytomegalovirus Infections
Human Genome
Cytomegalovirus
Glycoproteins
Amino Acids
Human herpesvirus 1 VP23 protein

ASJC Scopus subject areas

  • Immunology

Cite this

Occhino, M., Ghiotto, F., Soro, S., Mortarino, M., Bosi, S., Maffei, M., ... Ciccone, E. (2008). Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor. Journal of Immunology, 180(2), 957-968.

Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor. / Occhino, Marzia; Ghiotto, Fabio; Soro, Simonetta; Mortarino, Mimosa; Bosi, Stefania; Maffei, Massimo; Bruno, Silvia; Nardini, Marco; Figini, Mariangela; Tramontano, Anna; Ciccone, Ermanno.

In: Journal of Immunology, Vol. 180, No. 2, 15.01.2008, p. 957-968.

Research output: Contribution to journalArticle

Occhino, M, Ghiotto, F, Soro, S, Mortarino, M, Bosi, S, Maffei, M, Bruno, S, Nardini, M, Figini, M, Tramontano, A & Ciccone, E 2008, 'Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor', Journal of Immunology, vol. 180, no. 2, pp. 957-968.
Occhino, Marzia ; Ghiotto, Fabio ; Soro, Simonetta ; Mortarino, Mimosa ; Bosi, Stefania ; Maffei, Massimo ; Bruno, Silvia ; Nardini, Marco ; Figini, Mariangela ; Tramontano, Anna ; Ciccone, Ermanno. / Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor. In: Journal of Immunology. 2008 ; Vol. 180, No. 2. pp. 957-968.
@article{371b0ba5d00f4da582857d83e7c2087e,
title = "Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor",
abstract = "UL18 is a glycoprotein encoded by the human cytomegalovirus genome and is thought to play a pivotal role during human cytomegalovirus infection, although its exact function is still a matter of debate. UL18 shares structural similarity with MHC class I and binds the receptor CD85j on immune cells. Besides UL18, CD85j binds MHC class I molecules. The binding properties of CD85j to MHC class I molecules have been thoroughly studied. Conversely, very little information is available on the CD85j/UL18 complex, namely that UL18 binds CD85j through its α3 domain with an affinity that is ∼1000-fold higher than the MHC class I affinity for CD85j. Deeper knowledge of features of the UL18/CD85j complex would help to disclose the function of UL18 when it binds to CD85j. In this study we first demonstrated that the UL18α3 domain is not sufficient per se for binding and that β2-microglobulin is necessary for UL18-CD85j interaction. We then dissected structural determinants of binding UL18 to CD85j. To this end, we constructed a three-dimensional model of the complex. The model was used to design mutants in selected regions of the putative interaction interface, the effects of which were measured on binding. Six regions in both the α2 and α3 domains and specific amino acids within them were identified that are potentially involved in the UL18-CD85j interaction. The higher affinity of UL18 to CD85j, compared with MHC class I, seems to be due not to additional interaction regions but to an overall better fit of the two molecules.",
author = "Marzia Occhino and Fabio Ghiotto and Simonetta Soro and Mimosa Mortarino and Stefania Bosi and Massimo Maffei and Silvia Bruno and Marco Nardini and Mariangela Figini and Anna Tramontano and Ermanno Ciccone",
year = "2008",
month = "1",
day = "15",
language = "English",
volume = "180",
pages = "957--968",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor

AU - Occhino, Marzia

AU - Ghiotto, Fabio

AU - Soro, Simonetta

AU - Mortarino, Mimosa

AU - Bosi, Stefania

AU - Maffei, Massimo

AU - Bruno, Silvia

AU - Nardini, Marco

AU - Figini, Mariangela

AU - Tramontano, Anna

AU - Ciccone, Ermanno

PY - 2008/1/15

Y1 - 2008/1/15

N2 - UL18 is a glycoprotein encoded by the human cytomegalovirus genome and is thought to play a pivotal role during human cytomegalovirus infection, although its exact function is still a matter of debate. UL18 shares structural similarity with MHC class I and binds the receptor CD85j on immune cells. Besides UL18, CD85j binds MHC class I molecules. The binding properties of CD85j to MHC class I molecules have been thoroughly studied. Conversely, very little information is available on the CD85j/UL18 complex, namely that UL18 binds CD85j through its α3 domain with an affinity that is ∼1000-fold higher than the MHC class I affinity for CD85j. Deeper knowledge of features of the UL18/CD85j complex would help to disclose the function of UL18 when it binds to CD85j. In this study we first demonstrated that the UL18α3 domain is not sufficient per se for binding and that β2-microglobulin is necessary for UL18-CD85j interaction. We then dissected structural determinants of binding UL18 to CD85j. To this end, we constructed a three-dimensional model of the complex. The model was used to design mutants in selected regions of the putative interaction interface, the effects of which were measured on binding. Six regions in both the α2 and α3 domains and specific amino acids within them were identified that are potentially involved in the UL18-CD85j interaction. The higher affinity of UL18 to CD85j, compared with MHC class I, seems to be due not to additional interaction regions but to an overall better fit of the two molecules.

AB - UL18 is a glycoprotein encoded by the human cytomegalovirus genome and is thought to play a pivotal role during human cytomegalovirus infection, although its exact function is still a matter of debate. UL18 shares structural similarity with MHC class I and binds the receptor CD85j on immune cells. Besides UL18, CD85j binds MHC class I molecules. The binding properties of CD85j to MHC class I molecules have been thoroughly studied. Conversely, very little information is available on the CD85j/UL18 complex, namely that UL18 binds CD85j through its α3 domain with an affinity that is ∼1000-fold higher than the MHC class I affinity for CD85j. Deeper knowledge of features of the UL18/CD85j complex would help to disclose the function of UL18 when it binds to CD85j. In this study we first demonstrated that the UL18α3 domain is not sufficient per se for binding and that β2-microglobulin is necessary for UL18-CD85j interaction. We then dissected structural determinants of binding UL18 to CD85j. To this end, we constructed a three-dimensional model of the complex. The model was used to design mutants in selected regions of the putative interaction interface, the effects of which were measured on binding. Six regions in both the α2 and α3 domains and specific amino acids within them were identified that are potentially involved in the UL18-CD85j interaction. The higher affinity of UL18 to CD85j, compared with MHC class I, seems to be due not to additional interaction regions but to an overall better fit of the two molecules.

UR - http://www.scopus.com/inward/record.url?scp=40449096658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449096658&partnerID=8YFLogxK

M3 - Article

VL - 180

SP - 957

EP - 968

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -